Pregabalin for the management of fibromyalgia syndrome

References

• WolfeFSmytheHAYunusMBThe American College of Rheumatology 1990 Criteria for the Classification of FibromyalgiaArthritis Rheum1990331601722306288
   PubMed Web of Science ®Google Scholar
• NeumannLBuskilaDEpidemiology of fibromyalgiaCurr Pain Headache Rep2003736236812946289
   PubMedGoogle Scholar
• KatzRSWolfeFMichaudKFibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteriaArthritis Rheum200654116917616385512
   PubMed Web of Science ®Google Scholar
• SilvermanSDukesEMJohnsonSSBrandenburgNASadoskyAHuseDMThe economic burden of fibromyalgia: comparative analysis with rheumatoid arthritisCurr Med Res Opin200925482984019220165
   PubMed Web of Science ®Google Scholar
• CarvilleSFArendt-NielsenSBliddalHEULAR evidence-based recommendations for the management of fibromyalgia syndromeAnn Rheum Dis20086753654117644548
   PubMed Web of Science ®Google Scholar
• ScholzBAHammondsCLBoomershineCSDuloxetine for the management of fibromyalgia syndromeJ Pain Res2009299108
   PubMedGoogle Scholar
• OrmsethMJEylerAEHammondsCLBoomershineCSMilnacipran for the management of fibromyalgia syndromeJ Pain Res20103110
   Google Scholar
• Pfizer.com [homepage on the Internet]. Pfizer, Inc.; c2002–2009 [updated 2009 Dec]. Available from: http://www.pfizer.com/files/products/uspi_lyrica.pdf Accessed Mar 10, 2010.
   Google Scholar
• SpaethMIs pregabalin a safe and effective treatment for patients with fibromyalgia?Nat Clin Pract Rheumatol2008451451518762786
   PubMedGoogle Scholar
• FinkKDooleyDJMederWPInhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortexNeuropharmacology20024222923611804619
   PubMed Web of Science ®Google Scholar
• RussellIJOrrMDLittmanBElevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndromeArthrit Rheum1994371115931601
   PubMed Web of Science ®Google Scholar
• SarchielliPManciniMLFloridiAIncreased levels ofnNeurotrophinsa are not specific for chronic migraine: evidence from primary fibromyalgia syndromeJ Pain20078973774517611164
   PubMed Web of Science ®Google Scholar
• BaranauskasGNistriASensitization of pain pathways in the spinal cord: cellular mechanismsProg Neurobiol1998543493659481803
   PubMed Web of Science ®Google Scholar
• HauserWBernardyKUceylerNSommerCTreatment of fibromyalgia syndrome with gabapentin and pregabalin. A meta-analysis of randomized controlled trialsPain20091451–2698119539427
   PubMed Web of Science ®Google Scholar
• CroffordLJRowbothamMCMeasePJPregabalin for the treatment of fibromyalgia syndromeArthrit Rheum200552412641273
   PubMed Web of Science ®Google Scholar
• FarrarJTYoungJPJrLamoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain20019414915811690728
   PubMed Web of Science ®Google Scholar
• MeasePJRussellIJArnoldLMA randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgiaJ Rheumatol200835350251418278830
   PubMed Web of Science ®Google Scholar
• DworkinRHTurkDCFarrarJTCore outcome measure for chronic pain clinical trials: IMMPACT recommendationsPain200511391915621359
   PubMed Web of Science ®Google Scholar
• BurckhardtCSClarkSRBennettRMThe fibromyalgia impact questionnaire (FIQ): development and validationJ Rheumatol1991187287331865419
   PubMed Web of Science ®Google Scholar
• CroffordLJMeasePJSimpsonSLFibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalinPain200813641943118400400
   PubMed Web of Science ®Google Scholar
• BelzaBLComparison of self-reported fatigue in rheumatoid arthritis and controlsJ Rheumatol1995226396437791155
   PubMed Web of Science ®Google Scholar
• HaysRDStewartALStewartALWareJESleep Measures. Measuring Functioning and Well-being: The Medical Outcomes Study ApproachDurham, NCDuke University Press1992235259
   Google Scholar
• WareJESherbourneCDThe MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selectionMed Care1992304734831593914
   PubMed Web of Science ®Google Scholar
• ArnoldLMRussellIJDiriEWA 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgiaJ Pain20089979280518524684
   PubMed Web of Science ®Google Scholar
• BoomershineCSFirst pregabalin and now duloxetine for fibromyalgia syndrome: closer to a brave new world?Nat Clin Pract Rheumatol2008463663718982001
   PubMedGoogle Scholar
• PauerLPregabalin for management of fibromyalgia (FM): a 14-week, randomized, double-blind, placebo-controlled monotherapy trial (study A0081100)2008 Available from: http://www.clinicalstudyresults.org/drugdetails/?drug_id=4636 Accessed Apr 2, 2010.
   Google Scholar
• ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand1983673613706880820
   PubMed Web of Science ®Google Scholar
• StraubeSDerrySMooreRAMcQuayHJPregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reportsRheumatology20104970671520056767
   PubMed Web of Science ®Google Scholar
• ZhangWJonesADohertyMDoes paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trialsAnn Rheum Dis200463890190715020311
   PubMed Web of Science ®Google Scholar
• SultanAGaskellHDerrySMooreRADuloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomized trialsBMC Neurol200882918673529
   PubMed Web of Science ®Google Scholar
• BennettRMKaminMKarimRRosenthalNTramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled studyAm J Med200311453754512753877
   PubMed Web of Science ®Google Scholar
• BoomershineCSCroffordLJA symptom-based approach to pharmacologic management of fibromyalgiaNat Rev Rheumatol20095419119919337283
   PubMed Web of Science ®Google Scholar
• Eli Lilly and CompanyCymbalta presenbing information2004 Available from: http://pi.lilly.com/us/cymbalta-pi.pdf. Accessed Mar 19, 2010.
   Google Scholar
• Forest PharmaceuticalsSavella® presenbing information2009 Available from: http://www.frx.com/pi/Savella_pi.pdf. Accessed Mar 29, 2010.
   Google Scholar
• US Department of Health and Human ServicesFood and Drug AdministrationCenter for Drug Evaluation and ResearchOffice of Translational SciencesOffice of BiostatisticsStatistical Review and Evaluation: Antiepileptic Drugs and Suicidality20085 http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM192556.pdf Accessed Mar 22, 2010.
   Google Scholar
• HindmarchIA double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placeboSleep20052818719316171242
   PubMed Web of Science ®Google Scholar
• HidalgoRBTuplerLADavidsonJRTAn effect-size analysis of pharmacologic treatments for generalized anxiety disorderJ Psychopharmacol20072186487317984162
   PubMed Web of Science ®Google Scholar
• BechPDose-response relationship of pregabalin in patients with generalized anxeity disorderPharmacopsychiatry200740416316817694480
   PubMed Web of Science ®Google Scholar
• RaphaelKGJanalMNNayakSSchwartzJEGallagherRMPsychiatric comorbidities in a community sample of women with fibromyalgiaPain200612411712516698181
   PubMed Web of Science ®Google Scholar
• SimpsonDAGabapentin and venlafaxine for the treatment of painful diabetic neuropathyJ Clin Neuromuscul Dis20013536219078655
   PubMedGoogle Scholar